[go: up one dir, main page]

FI934725A0 - Kombinationsvaccin mot barnsjukdomar med oekad immunogenicitet hos varje vaccinkomponent - Google Patents

Kombinationsvaccin mot barnsjukdomar med oekad immunogenicitet hos varje vaccinkomponent

Info

Publication number
FI934725A0
FI934725A0 FI934725A FI934725A FI934725A0 FI 934725 A0 FI934725 A0 FI 934725A0 FI 934725 A FI934725 A FI 934725A FI 934725 A FI934725 A FI 934725A FI 934725 A0 FI934725 A0 FI 934725A0
Authority
FI
Finland
Prior art keywords
combined
combination vaccine
vaccine composition
compartment
vaccine compartment
Prior art date
Application number
FI934725A
Other languages
English (en)
Other versions
FI934725L (fi
FI934725A7 (fi
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI934725A0 publication Critical patent/FI934725A0/fi
Publication of FI934725L publication Critical patent/FI934725L/fi
Publication of FI934725A7 publication Critical patent/FI934725A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
FI934725A 1992-10-27 1993-10-26 Lastentauteihin tarkoitettu yhdistelmärokote, jonka kunkin rokotekomponentin immunogeenisyys on lisääntynyt FI934725A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (3)

Publication Number Publication Date
FI934725A0 true FI934725A0 (fi) 1993-10-26
FI934725L FI934725L (fi) 1994-04-28
FI934725A7 FI934725A7 (fi) 1994-04-28

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934725A FI934725A7 (fi) 1992-10-27 1993-10-26 Lastentauteihin tarkoitettu yhdistelmärokote, jonka kunkin rokotekomponentin immunogeenisyys on lisääntynyt

Country Status (22)

Country Link
EP (1) EP0594950B1 (fi)
JP (1) JPH07300427A (fi)
KR (1) KR100289224B1 (fi)
AT (1) ATE176157T1 (fi)
AU (1) AU669570B2 (fi)
CA (1) CA2109159A1 (fi)
CZ (1) CZ283587B6 (fi)
DE (2) DE69323264T4 (fi)
DK (1) DK0594950T3 (fi)
ES (1) ES2126616T3 (fi)
FI (1) FI934725A7 (fi)
GR (1) GR3029884T3 (fi)
HU (1) HU215149B (fi)
IL (1) IL107387A (fi)
LV (1) LV12271B (fi)
NO (1) NO308588B1 (fi)
NZ (1) NZ250029A (fi)
PL (1) PL174130B1 (fi)
RU (1) RU2121365C1 (fi)
SG (1) SG47725A1 (fi)
TW (1) TW256774B (fi)
UA (1) UA27754C2 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
ATE400295T1 (de) * 1995-06-07 2008-07-15 Glaxosmithkline Biolog Sa Vakzine mit einem polysaccharide antigen- trägerprotein konjugat und freiem trägerprotein
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
DE69612198T3 (de) * 1995-06-23 2011-08-18 Smithkline Beecham Biologicals S.A. Eine Impfstoffzusammensetzung, bestehend aus einem Haemophilus influenzae B Polysaccharid Antigen-Konjugat adsorbiert an Aluminiumphosphat
CA2259415A1 (en) * 1996-07-02 1998-01-08 Connaught Laboratories Limited Multivalent dtp-polio vaccines
GB0108364D0 (en) 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
HU227893B1 (en) * 2000-06-29 2012-05-29 Glaxosmithkline Biolog Sa Vaccine compositions
RU2175557C1 (ru) * 2000-09-04 2001-11-10 Волков Александр Григорьевич Способ предупреждения воспалительных заболеваний верхних дыхательных путей
AU2002330681C1 (en) * 2001-07-26 2015-04-02 Glaxosmithkline Biologicals S.A. Vaccines comprising aluminium adjuvants and histidine
WO2004039399A1 (en) 2002-11-01 2004-05-13 Glaxosmithkline Biologicals S.A. Immunogenic composition
RU2231793C1 (ru) * 2003-03-11 2004-06-27 Москаленко Екатерина Петровна Способ оценки иммуногенности коклюшных вакцин
RU2244548C1 (ru) * 2003-07-17 2005-01-20 Оренбургская государственная медицинская академия (ОГМА) Средство, повышающее иммуногенные свойства столбнячного анатоксина
RU2274474C1 (ru) * 2004-10-12 2006-04-20 Государственное образовательное учреждение ВПО Красноярская государственная медицинская академия Министерства здравоохранения РФ Способ вакцинации детей против краснухи на крайнем севере
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
KR20130122810A (ko) 2005-06-27 2013-11-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법
RU2303459C1 (ru) * 2005-12-05 2007-07-27 ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) Способ вакцинации детей против краснухи на крайнем севере
RU2299744C1 (ru) * 2006-03-02 2007-05-27 ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ сезонной ревакцинации детей против краснухи на крайнем севере

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
DK163176C (da) * 1985-09-27 1992-06-22 Schweiz Serum & Impfinst Ugiftig konjugatvaccine mod infektioner af pseudomonas aeruginosa- og escherichia coli- bakterier, fremgangsmaade til fremstilling heraf og anvendelse af vaccinen

Also Published As

Publication number Publication date
IL107387A0 (en) 1994-01-25
CZ227293A3 (en) 1994-05-18
DE69323264D1 (de) 1999-03-11
FI934725L (fi) 1994-04-28
SG47725A1 (en) 1998-04-17
HUT67239A (en) 1995-03-28
NO308588B1 (no) 2000-10-02
KR940008698A (ko) 1994-05-16
LV12271A (lv) 1999-05-20
NZ250029A (en) 1994-09-27
HK1009931A1 (en) 1999-06-11
ES2126616T3 (es) 1999-04-01
JPH07300427A (ja) 1995-11-14
CZ283587B6 (cs) 1998-05-13
AU669570B2 (en) 1996-06-13
ATE176157T1 (de) 1999-02-15
DE69323264T4 (de) 1999-10-14
PL174130B1 (pl) 1998-06-30
CA2109159A1 (en) 1994-04-28
UA27754C2 (uk) 2000-10-16
NO933856L (no) 1994-04-28
IL107387A (en) 1997-04-15
LV12271B (en) 1999-07-20
HU9303028D0 (en) 1994-01-28
KR100289224B1 (ko) 2001-05-02
FI934725A7 (fi) 1994-04-28
EP0594950A1 (en) 1994-05-04
GR3029884T3 (en) 1999-07-30
DK0594950T3 (da) 1999-09-13
RU2121365C1 (ru) 1998-11-10
TW256774B (fi) 1995-09-11
AU5029093A (en) 1994-05-12
NO933856D0 (no) 1993-10-26
EP0594950B1 (en) 1999-01-27
DE69323264T2 (de) 1999-06-02
HU215149B (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
FI934725A0 (fi) Kombinationsvaccin mot barnsjukdomar med oekad immunogenicitet hos varje vaccinkomponent
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
GR3035081T3 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
FI914564A0 (fi) Foerbaettrade konjugerade oligosackaridvacciner.
Alexander et al. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®)
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
DE69518978D1 (de) Gruppe a streptokokkenpolysaccharide immunogen-zusammensetzungen und verfahren
MXPA04006073A (es) Vacuna.
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
DE68915046D1 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
US6165468A (en) Antigenic carbohydrate linked to an immunogenic carrier
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.
Egorkov et al. Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.
SE8400934D0 (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner